Chugai Pharmaceutical (CHGCY) News Today $23.73 -0.39 (-1.62%) (As of 09/13/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 Time Period September 12 at 8:41 PM | marketbeat.comChugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY) Sees Significant Decrease in Short InterestChugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY - Get Free Report) saw a significant decrease in short interest during the month of August. As of August 31st, there was short interest totalling 400 shares, a decrease of 96.9% from the August 15th total of 12,900 shares. Based on an average daily volume of 154,300 shares, the days-to-cover ratio is currently 0.0 days.August 31, 2024 | seekingalpha.comHarding Loevner International Equity ADR Q2 2024 ReportAugust 30, 2024 | investing.comChugai Pharmaceutical Co Ltd ADR (CHGCY)August 27, 2024 | marketbeat.comChugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY) Short Interest UpdateChugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY - Get Free Report) saw a significant increase in short interest in the month of August. As of August 15th, there was short interest totalling 12,900 shares, an increase of 545.0% from the July 31st total of 2,000 shares. Based on an average trading volume of 106,800 shares, the days-to-cover ratio is currently 0.1 days.August 22, 2024 | marketbeat.comChugai Pharmaceutical (OTCMKTS:CHGCY) Reaches New 12-Month High at $25.36Chugai Pharmaceutical (OTCMKTS:CHGCY) Hits New 1-Year High at $25.36August 15, 2024 | marketbeat.comChugai Pharmaceutical (OTCMKTS:CHGCY) Reaches New 52-Week High at $22.92Chugai Pharmaceutical (OTCMKTS:CHGCY) Reaches New 52-Week High at $22.92August 13, 2024 | marketbeat.comChugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY) Short Interest Down 90.3% in JulyChugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY - Get Free Report) saw a large decrease in short interest in the month of July. As of July 31st, there was short interest totalling 2,000 shares, a decrease of 90.3% from the July 15th total of 20,700 shares. Based on an average trading volume of 189,900 shares, the short-interest ratio is presently 0.0 days.July 27, 2024 | seekingalpha.comChugai Pharmaceutical Co., Ltd. (CHGCF) Q2 2024 Earnings Call TranscriptJuly 25, 2024 | msn.comChugai Pharmaceutical reports 1H resultsJune 28, 2024 | marketbeat.comShort Interest in Chugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY) Rises By 66.7%Chugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY - Get Free Report) was the target of a significant growth in short interest in June. As of June 15th, there was short interest totalling 6,000 shares, a growth of 66.7% from the May 31st total of 3,600 shares. Based on an average daily trading volume, of 128,100 shares, the days-to-cover ratio is currently 0.0 days.June 12, 2024 | marketbeat.comShort Interest in Chugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY) Declines By 96.0%Chugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY - Get Free Report) saw a significant decrease in short interest in the month of May. As of May 31st, there was short interest totalling 3,600 shares, a decrease of 96.0% from the May 15th total of 90,300 shares. Based on an average daily trading volume, of 199,900 shares, the days-to-cover ratio is presently 0.0 days.April 27, 2024 | marketbeat.comChugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY) Short Interest Down 52.3% in AprilChugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY - Get Free Report) was the recipient of a large drop in short interest in April. As of April 15th, there was short interest totalling 53,000 shares, a drop of 52.3% from the March 31st total of 111,100 shares. Based on an average trading volume of 906,800 shares, the short-interest ratio is presently 0.1 days.April 26, 2024 | seekingalpha.comChugai Pharmaceutical Co., Ltd. (CHGCF) Q1 2024 Earnings Call TranscriptApril 23, 2024 | markets.businessinsider.comChugai Pharmaceutical is about to announce its earnings — here's what Wall Street expectsApril 10, 2024 | marketbeat.comChugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY) Sees Large Increase in Short InterestChugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY - Get Free Report) was the target of a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 111,100 shares, an increase of 439.3% from the March 15th total of 20,600 shares. Based on an average daily volume of 216,900 shares, the days-to-cover ratio is presently 0.5 days.March 30, 2024 | marketbeat.comShort Interest in Chugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY) Drops By 17.6%Chugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY - Get Free Report) was the recipient of a large drop in short interest during the month of March. As of March 15th, there was short interest totalling 20,600 shares, a drop of 17.6% from the February 29th total of 25,000 shares. Based on an average daily trading volume, of 135,600 shares, the days-to-cover ratio is currently 0.2 days.March 12, 2024 | marketbeat.comChugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY) Short Interest Up 635.3% in FebruaryChugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY - Get Free Report) was the recipient of a significant growth in short interest in February. As of February 29th, there was short interest totalling 25,000 shares, a growth of 635.3% from the February 14th total of 3,400 shares. Based on an average daily trading volume, of 240,700 shares, the days-to-cover ratio is presently 0.1 days.February 25, 2024 | msn.comChugai Pharmaceutical Co., - Depositary Receipt () (CHGCY) Price Target Increased by 5.85% to 19.64February 21, 2024 | au.finance.yahoo.comChugai Pharmaceutical Co Ltd (CUP.HA)February 18, 2024 | seekingalpha.comWeek In Review: LianBio To Close Operations; Will Pay $528M To ShareholdersFebruary 17, 2024 | finance.yahoo.comChugai Pharmaceutical Co., Ltd. (CHGCY)February 16, 2024 | wsj.comChugai Pharmaceutical Co. Ltd. ADRFebruary 13, 2024 | au.finance.yahoo.comChugai Pharmaceutical Co Ltd (CUP.MU)February 6, 2024 | investing.comChugai Pharmaceutical Co., Ltd. (4519)January 25, 2024 | finance.yahoo.comU.S. Stocks Rise as Economic Growth ContinuesJanuary 25, 2024 | finance.yahoo.comU.S. Stocks Rise After Strong GDP DataJanuary 25, 2024 | finance.yahoo.comFutures Steady With More Earnings in FocusJanuary 24, 2024 | finance.yahoo.comNikkei Down 0.3%, Dragged by Tech, Pharmaceutical StocksJanuary 11, 2024 | marketbeat.comChugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY) Sees Large Decrease in Short InterestChugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY - Get Free Report) was the recipient of a large decline in short interest during the month of December. As of December 31st, there was short interest totalling 2,500 shares, a decline of 89.9% from the December 15th total of 24,800 shares. Based on an average daily volume of 88,300 shares, the days-to-cover ratio is presently 0.0 days.January 4, 2024 | morningstar.comChugai Pharmaceutical Co Ltd ADR CHGCYDecember 29, 2023 | marketbeat.comChugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY) Sees Large Growth in Short InterestChugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY - Get Free Report) was the recipient of a significant increase in short interest in the month of December. As of December 15th, there was short interest totalling 24,800 shares, an increase of 140.8% from the November 30th total of 10,300 shares. Based on an average trading volume of 100,400 shares, the short-interest ratio is presently 0.2 days.December 17, 2023 | seekingalpha.comWeek In Review: SystImmune Out-Licenses Global Rights For ADC To BMS In $8.4B DealDecember 16, 2023 | msn.comChugai Pharmaceutical Co Ltd - ADR (CHGCY) Price Target Increased by 14.02% to 19.28December 12, 2023 | finance.yahoo.comChugai Pharmaceutical Co., Ltd. (CUP0.MU)November 29, 2023 | morningstar.comChugai Pharmaceutical Co Ltd CUPNovember 18, 2023 | morningstar.comChugai Pharmaceutical Co LtdOctober 23, 2023 | markets.businessinsider.comChugai Pharmaceutical earnings: here's what to expectOctober 12, 2023 | finance.yahoo.comChugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) Is a Great Choice for 'Trend' Investors, Here's WhyOctober 5, 2023 | finance.yahoo.comChugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) Upgraded to Buy: Here's What You Should KnowSeptember 1, 2023 | investing.comTOPIX Pharmaceutical (IPHAM.T)August 19, 2023 | wsj.comChugai Pharmaceutical Co. Ltd.August 3, 2023 | msn.comChugai Pharmaceutical (CHGCF) Price Target Decreased by 6.55% to 30.71April 26, 2023 | markets.businessinsider.comHere's what to expect from Chugai Pharmaceutical's earnings reportApril 18, 2023 | seekingalpha.comCHGCY Chugai Pharmaceutical Co., Ltd.March 2, 2023 | msn.comChugai, Biofourmis expand team up on digital solutions to measure endometriosis painMarch 2, 2023 | finance.yahoo.comChugai and Biofourmis Enter into New Partnership Focused on Data-Driven Virtual Care for Endometriosis-Related PainDecember 30, 2022 | seekingalpha.comRoche: Worthy Of Big Pharma Label, Maybe Not A 'Value Pick' YetDecember 14, 2022 | finance.yahoo.comVisiox Pharma Announces FDA Acceptance of New Drug Application for GlaucomaDecember 12, 2022 | benzinga.comShort Volatility Alert: Chugai Pharm CoApril 27, 2022 | seekingalpha.comChugai Pharmaceutical reports Q1 results Get Chugai Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for CHGCY and its competitors with MarketBeat's FREE daily newsletter. Email Address War on Elon Escalates… (Ad)One company holds a near-total monopoly on this technology. Elon Musk is one of the few people who knows this. That’s why in his recent interview with Trump, he brought up this technology as a viable solution to America’s growing energy needs. What is this technology and why has it put Elon in the middle of an ideological war with the elites? Watch my new exposé and find out. CHGCY Media Mentions By Week CHGCY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CHGCY News Sentiment▼0.860.69▲Average Medical News Sentiment CHGCY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CHGCY Articles This Week▼20▲CHGCY Articles Average Week Get Chugai Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for CHGCY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: McKesson News Cencora News Cardinal Health News PetIQ News Herbalife News Nu Skin Enterprises News Cosmos Health News TRxADE HEALTH News HWH International News BIMI News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:CHGCY) was last updated on 9/14/2024 by MarketBeat.com Staff From Our PartnersThe death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chugai Pharmaceutical Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Chugai Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.